← 返回前沿论文

胃癌中脏坏死与肿瘤坏死的预后评估

英文原题:Prognostic evaluation of dirty necrosis and tumor necrosis in gastric cancers.

PubMed 2026/02/11(内容时间) Sci Rep Q1 · IF 4.9(JCR 2025)

研究概要

本研究强调了重新评估坏死类型在胃癌预后和治疗策略中的重要性。

中文摘要

本研究考察肿瘤坏死和“污秽性坏死”对胃癌预后的意义。肿瘤坏死常与肿瘤快速生长和血管化不足相关,是多种癌症中已知的不良预后指标。“污秽性坏死”是一种伴有中性粒细胞和坏死碎屑的特殊形态,在结直肠癌和肾细胞癌等肿瘤中具有预后价值。肿瘤相关中性粒细胞(TAN)及中性粒细胞释放细胞外捕获网的过程(NETosis)也参与肿瘤进展和预后。本研究纳入在埃斯基谢希尔奥斯曼加齐大学接受手术的187例胃癌患者。39.6%的病例存在污秽性坏死,且其与肿瘤类型、分级、淋巴结分期及TIL存在显著关联。研究发现污秽性坏死与更长的无复发生存期和总生存期相关。此外,存在污秽性坏死且TIL明显的患者生存结局更佳。结果提示,胃癌中的污秽性坏死,尤其是伴随TIL时,可能指示较好预后。本研究强调应重新评估不同坏死类型在胃癌预后判断和治疗策略中的意义。

展开英文摘要原文

This study examines the prognostic significance of tumor necrosis and dirty necrosis in gastric cancer. Tumor necrosis, often linked to rapid tumor growth and insufficient vascularization, is a known poor prognostic indicator in several cancer types. Dirty necrosis, a special form seen with neutrophils and necrotic debris, has prognostic value in cancers like colorectal carcinoma and renal cell carcinoma. The presence of tumor-associated neutrophils (TANs) and NETosis, a process where neutrophils release extracellular traps, also plays a role in tumor progression and prognosis. This study included 187 gastric cancer patients who underwent surgery at Eskisehir Osmangazi University. Dirty necrosis was present in 39.6% of cases, with significant associations found between dirty necrosis and tumor type, grade, lymph node stage, and TIL presence. The study demonstrated that dirty necrosis correlated with longer recurrence-free survival and overall survival. Additionally, patients with dirty necrosis and prominent TILs exhibited improved survival outcomes. The findings suggest that dirty necrosis, particularly when associated with TIL, may indicate a better prognosis in gastric cancer. This study highlights the importance of re-evaluating necrosis types in gastric cancer prognosis and treatment strategies.

论文信息

作者
Şeker NS、Mülkem OF、Yılmaz E、Canaz F、Demir M、Yıldız B、Ağdaş G、Bilgin M
单位
Department of Pathology, Eskişehir Osmangazi University Faculty of Medicine, Meşelik Campus, Eskişehir, 26480, Turkey. nazlisenaerdem@gmail.com.Turkey
期刊
Scientific reports2026 Feb 11
原文标识
PubMed 41673085 · DOI 10.1038/s41598-026-39605-1